SUNPHARMA awakens from slumber.

Well, atleast the charts say so.The stock on the weekly horizon is making an Inverted Head and Shoulders, the target for which comes to be about 680 odd levels. On the daily horizon, the stock is well above the key EMAs. Besides, the price shows no divergence with respect to the RSI and Stochastics.
This post is solely for education purpose.